Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Publikováno v:
British Journal of Cancer
background: Health systems are facing the challenge of providing care to an increasing population of patients with cancer. However, evidence on costs is limited due to the lack of large longitudinal databases.\ud \ud methods: We matched cost of care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e5a32d96c7a85cceb10d21f81265dc
https://openaccess.city.ac.uk/id/eprint/14426/1/bjc201677a.pdf
https://openaccess.city.ac.uk/id/eprint/14426/1/bjc201677a.pdf
Autor:
Alice M Turner, Roy Bicknell, John Herbert, J Bradford, David R Thickett, Simon T. Barry, Darren Cross, P Lodhia, David C. Blakey, Xiaodong Zhuang, U Naidu, P M Newby
Publikováno v:
British Journal of Cancer
Background: Lung cancer remains the leading cause of cancer-related death, largely owing to the lack of effective treatments.\ud A tumour vascular targeting strategy presents an attractive alternative; however, the molecular signature of the vasculat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9fed9d2e25994f2fac3e40127761073
Autor:
Eldo T. Verghese, David G. Jayne, Nicholas P. West, SL Perry, S Yeluri, J. P. Tiernan, Thomas A. Hughes
Publikováno v:
British Journal of Cancer
Background: Colorectal cancer-specific biomarkers have been used as molecular targets for fluorescent intra-operative imaging, targeted PET/MRI, and selective cytotoxic drug delivery yet the selection of biomarkers used is rarely evidence-based. We e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce7097d3ceb1f9881c700650bcb15df
Autor:
S. L. Maloney, M A Voss, Keith McCarthy, L Ludeman, Sudha Sundar, Naheema S. Gordon, R Gornall, G Schaller, Raji Ganesan, Wenbin Wei, Fedor Berditchevski
Publikováno v:
British Journal of Cancer
Background: Type II cancers account for 10% of endometrial cancers but 50% of recurrence. Response rates to chemotherapy at recurrence are poor and better prognostic markers are needed to guide therapy. CD151 is a small transmembrane protein that reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d4368a517da6096019d30c5f69e51e
Publikováno v:
British Journal of Cancer
Necrosis is a common feature of invasive carcinoma of the breast and is caused by chronic ischaemia leading to infarction. Although necrosis was previously assumed to be due to a generally poor blood supply in the tumour, in this study we show that i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5b8df344756e877da427650f0759d2